FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Song, Weifeng ^a,b   Li, Qi ^a,b   Wang, Lei ^a   Huang, Weiyi ^a   Wang, Liwei ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Key Laboratory of Pancreatic Diseases Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN; RNA; TRANSCRIPTION FACTOR FKHR;

ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; GENETICS; HUMAN; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; RNA, NEOPLASM;

EID: 84931259652     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10081     Document Type: Article

References (36)

1. Han, H., Von Hoff, D. D. SnapShot: pancreatic cancer. Cancer Cell 23, 424-424 e421, doi:10. 1016/j. ccr. 2013. 03. 008 (2013).
2. Shi, W. et al. Cyr61 promotes growth of pancreatic carcinoma via nuclear exclusion of p27. Tumour Biol. 35, 11147-11151, doi:10. 1007/s13277-014-2423-x (2014).
3. di Magliano, M. P., Logsdon, C. D. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology 144, 1220-1229, doi:10. 1053/j. gastro. 2013. 01. 071 (2013).
4. Petersson, M., Niemann, C. Stem cell dynamics and heterogeneity: implications for epidermal regeneration and skin cancer. Curr. Med. Chem. 19, 5984-5992 (2012).
5. Perez-Losada, J., Balmain, A. Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer 3, 434-443, doi:10. 1038/nrc1095 (2003).
6. Singh, S. R. Stem cell niche in tissue homeostasis, aging and cancer. Curr. Med. Chem. 19, 5965-5974 (2012).
7. Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
8. Nagata, T. et al. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 31, 495-500 (2011).
9. Fang, D. D. et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br. J. Cancer 102, 1265-1275, doi:10. 1038/sj. bjc. 6605610 (2010).
10. Shi, C. et al. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol. Ther. 10, 1182-1190 (2010).
11. Ottaiano, A. Finding markers for cancer stem cells in renal cell carcinoma: looking beyond CD133. Cell Cycle 9, 4431 (2010).
12. Ma, S. et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 6, 1146-1153, doi:10. 1158/1541-7786. MCR-08-0035 (2008).
13. Wang, J. et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer. 122, 761-768, doi:10. 1002/ijc. 23130 (2008).
14. Duester, G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267, 4315-4324 (2000).
15. Magni, M. et al. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87, 1097-1103 (1996).
16. Armstrong, L. et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22, 1142-1151, doi:10. 1634/stemcells. 2004-0170 (2004).
17. Hess, D. A. et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 26, 611-620, doi:10. 1634/stemcells. 2007-0429 (2008).
18. Hess, D. A. et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104, 1648-1655, doi:10. 1182/blood-2004-02-0448 (2004).
19. Hess, D. A. et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107, 2162-2169, doi:10. 1182/blood-2005-06-2284 (2006).
20. Silva, I. A. et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 71, 3991-4001, doi:10. 1158/0008-5472. CAN-10-3175 (2011).
21. Ma, I., Allan, A. L. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7, 292-306, doi:10. 1007/s12015-010-9208-4 (2011).
22. Liu, Y. et al. Proliferating pancreatic beta-cells upregulate ALDH. Histochem Cell Biol., doi:10. 1007/s00418-014-1248-4 (2014).
23. Zhang, L. et al. ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. PLoS One 9, e96204, doi:10. 1371/journal. pone. 0096204 (2014).
24. Sicard, F., Gayral, M., Lulka, H., Buscail, L., Cordelier, P. Targeting miR-21 for the therapy of pancreatic cancer. Mol. Ther. 21, 986-994, doi:10. 1038/mt. 2013. 35 (2013).
25. Tavano, F. et al. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas 41, 1280-1284, doi:10. 1097/MPA. 0b013e31824c11f4 (2012).
26. Ali, S. et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res. 70, 3606-3617, doi:10. 1158/0008-5472. CAN-09-4598 (2010).
27. Gross, D. N., van den Heuvel, A. P., Birnbaum, M. J. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320-2336, doi:10. 1038/onc. 2008. 25 (2008).
28. Song, W., Li, Q., Wang, L., Wang, L. Modulation of FoxO1 Expression by miR-21 to Promote Growth of Pancreatic Ductal Adenocarcinoma. Cell Physiol. Biochem. 35, 184-190, doi:10. 1159/000369686 (2015).
29. Lieber, M., Mazzetta, J., Nelson-Rees, W., Kaplan, M., Todaro, G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int. J. Cancer 15, 741-747 (1975).
30. Khan, I. F., Hirata, R. K., Russell, D. W. AAV-mediated gene targeting methods for human cells. Nat. Protoc. 6, 482-501, doi:10. 1038/nprot. 2011. 301 (2011).
31. Hajitou, A. et al. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat. Protoc. 2, 523-531, doi:10. 1038/nprot. 2007. 51 (2007).
32. Grieger, J. C., Choi, V. W., Samulski, R. J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412-1428, doi:10. 1038/nprot. 2006. 207 (2006).
33. Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593-605, doi:10. 1002/dvg. 20335 (2007).
34. Xiao, X. et al. No evidence for beta cell neogenesis in murine adult pancreas. J. Clin. Invest. 123, 2207-2217, doi:10. 1172/JCI66323 (2013).
35. Cao, X., Han, Z. B., Zhao, H., Liu, Q. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. Int. J. Biochem. Cell Biol. 53, 372-379, doi:10. 1016/j. biocel. 2014. 06. 003 (2014).
36. Liu, S. et al. Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma. Tumour Biol. 35, 11605-11612, doi:10. 1007/s13277-014-2488-6 (2014).